Article

Current Therapeutic Opportunities for Estrogen Receptor Mutant Breast Cancer

2024-11-05

Abstract excerpt

Estrogen receptor α (ERα) drives 2 out of 3 breast cancers and therefore ERα is a major therapeutic target for ER-positive breast cancer patients. Drugs that inhibit ERα activity or block estrogen synthesis in the body are currently being used in the clinic to treat ER-positive breast cancer and have been quite successful in controlling breast cancer progression for the majority of patients. However, ER-positive b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8db4b43a-20c8-5e6f-950a-74cacfe958b3
DOI: 10.20944/preprints202411.0222.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Current Therapeutic Opportunities for Estrogen Receptor Mutant Breast CancerDOI 10.20944/preprints202411.0222.v1Read

Estrogen receptor mutations and functional consequences for breast cancer.Semantic proximity Read

ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges.Semantic proximity Read

A Closer Look at Estrogen Receptor Mutations in Breast Cancer and Their Implications for Estrogen and Antiestrogen Responses.Semantic proximity Read

Estrogen Receptor Alpha and ESR1 Mutations in Breast Cancer.Semantic proximity Read

Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies.Semantic proximity Read

Activating ESR1 mutations in hormone-resistant metastatic breast cancer.Semantic proximity Read

Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer.Semantic proximity Read

Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight.Semantic proximity Read

Clinically Observed Estrogen Receptor Alpha Mutations within the Ligand-Binding Domain Confer Distinguishable Phenotypes.Semantic proximity Read

Decoding estrogen receptor and GPER biology: structural insights and therapeutic advances in ERα−positive breast cancerSemantic proximity Read

Estrogen receptor mutations and their role in breast cancer progression.Semantic proximity Read

ESR1 activating mutations: From structure to clinical application.Semantic proximity Read